55 Trending Stocks

Thu, Jan 21, 2021

Amgen

AMGN 250.68
1.68 (0.7%)

Open: 252.00 High: 252.73 Low: 249.52

9 x 250.68 = 2256.12
x $250.68 =

NASDAQ: AMGN $146 Billion Large-Cap. Dow Industrial. Nasdaq 100. S&P 500. Health Care Sector. Biotech & Pharma Industry. 5 Year Return 61%. 1 Year Return 6%. 2021 YTD Return 11%. 2.8% dividend yield. 39 total dividend payments. Current Ex-Date in 21 days on Thu, Feb 11. Since Earnings 1%.

ST

External Links

Charts

image
image

52WL $181.77

The 52 Week Low is $181.77 set on Thu, Mar 12, 2020.

52WH $262.82

The 52 Week High is $262.82 set on Mon, Jul 20, 2020.

ATH $262.82

The All-Time High is $262.82 set on Mon, Jul 20, 2020.

52 Week Range

$181.77
$262.82
Mar 12, 2020
Jul 20, 2020

Earnings

3.45

Earnings Per Share

15.15

Price To Earnings Ratio


Q1 Earnings for Jan, Feb & Mar

Thu, Apr 30, 2020

Since Q1 Earnings Report

AMGN 6.4%


Q2 Earnings for Apr, May & Jun

Tue, Jul 28, 2020

Since Q2 Earnings Report

AMGN 1.2%

Dividends

2.81

Dividend Yield

7.04

Dividend Rate

Thu, Feb 11, 2021

Ex-Dividend Date

Mon, Mar 8, 2021

Dividend Payment Date

Quarterly

Dividend Frequency

39

Dividend History

Profile

Amgen trades on the NASDAQ. AMGN's market cap is 145.9 Billion.

Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and received approval for bone-strengthening drug Prolia/Xgeva in 2010. Amgen's acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Nexavar and Kyprolis. Recent launches include Repatha (cholesterol-lowering) and Aimovig (migraine).

Website

Related Channels

Free Channels & more...

For Starters

Account Channels

Track your portfolio and more.